Amit Etkin, M.D., Ph.D., founder and chief executive officer of Alto Neuroscience, Inc., was recently named a finalist for the prestigious Entrepreneur Of The Year® 2023 Bay Area Award. This esteemed award is in its 37th year and recognizes entrepreneurs and leaders of high-growth companies who are driving innovation and creating a more equitable and prosperous world.
Etkin’s nomination is a testament to his dedication to making a positive impact on the world through his pioneering work at Alto Neuroscience, Inc.
Dr. Etkin has been recognized for his commitment to creating long-term, sustainable value through his innovative spirit, meaningful purpose, and significant growth and impact. An esteemed panel of independent judges selected him for this honor, recognizing his core contributions and outstanding attributes.
I am truly humbled to be selected as a finalist for EY’s Entrepreneur Of The Year alongside other esteemed business leaders in the Bay Area. Taking the risk to depart from my Stanford post to launch Alto Neuroscience was a daring move, but it has paid off in spades.
I am incredibly proud of all that we have achieved in mental health research and medicine, and I owe it all to the hardworking team at Alto who have helped bring our vision to life.
Since its establishment in 1986, the Entrepreneur Of The Year program has recognized more than 11,000 entrepreneurs across the US and has since expanded to honor business leaders in 145 cities across 60 countries worldwide! This esteemed program continues to celebrate and recognize the achievements of the world’s most inspiring entrepreneurs.
About Entrepreneur Of The Year®
Entrepreneur Of The Year® is the world’s most prestigious business awards program for unstoppable entrepreneurs who are determined to make an impact. By fostering a culture of innovation, growth and prosperity, these visionary leaders are transforming our world.
Through regional and national awards programs across more than 145 cities in over 60 countries, Entrepreneur Of The Year celebrates and connects entrepreneurs, providing them with invaluable insights and experiences to help them reach their full potential. The best of the best will even have the opportunity to compete for the EY World Entrepreneur Of The Year™ title.
At EY, we strive to build a better working world by providing long-term value for clients, people and society, and by creating trust in the capital markets. Our diverse teams, located in over 150 countries, leverage data and technology to provide assurance and help clients grow, transform and operate. With expertise in assurance, consulting, law, strategy, tax and transactions, EY teams are driven to ask better questions and find new answers to the complex issues facing the world today.
At Ernst & Young, we are a global organization comprised of member firms, each of which is a separate legal entity. We provide a wide range of services to our clients, and we take the privacy of their data very seriously.
We comply with all applicable data protection legislation and are committed to protecting the rights of individuals. Our members are also prohibited from practicing law in certain jurisdictions. With us, you can be sure that your data is secure and your rights are respected.
About Alto Neuroscience
Alto Neuroscience is revolutionizing the world of psychiatry with its Precision Psychiatry Platform™, a revolutionary approach to matching each patient with the right drug for their individual needs. By analyzing EEG activity, behavioral task performance, wearable data, genetics, and other factors, Alto has identified core domains of mental function (cognition, emotion, and sleep processes) and created a multiple modality approach to accurately predict a patient’s drug responses.
With a clinical-stage pipeline of first- or best-in-class drug candidates in depression, PTSD, and other mental health conditions, Alto is leading the way in precision psychiatry.